417 related articles for article (PubMed ID: 20067770)
1. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
[TBL] [Abstract][Full Text] [Related]
2. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
[TBL] [Abstract][Full Text] [Related]
3. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
[TBL] [Abstract][Full Text] [Related]
4. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
[TBL] [Abstract][Full Text] [Related]
6. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1.
Koeberle A; Siemoneit U; Bühring U; Northoff H; Laufer S; Albrecht W; Werz O
J Pharmacol Exp Ther; 2008 Sep; 326(3):975-82. PubMed ID: 18550688
[TBL] [Abstract][Full Text] [Related]
7. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
[TBL] [Abstract][Full Text] [Related]
8. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
Moon Y; Glasgow WC; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
[TBL] [Abstract][Full Text] [Related]
9. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1.
Jüngel A; Distler O; Schulze-Horsel U; Huber LC; Ha HR; Simmen B; Kalden JR; Pisetsky DS; Gay S; Distler JH
Arthritis Rheum; 2007 Nov; 56(11):3564-74. PubMed ID: 17968936
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.
Kats A; Båge T; Georgsson P; Jönsson J; Quezada HC; Gustafsson A; Jansson L; Lindberg C; Näsström K; Yucel-Lindberg T
FASEB J; 2013 Jun; 27(6):2328-41. PubMed ID: 23447581
[TBL] [Abstract][Full Text] [Related]
11. Regulation of prostaglandin E synthases: effects of siRNA-mediated inhibition of microsomal prostaglandin E synthase-1.
Båge T; Modéer T; Kawakami T; Quezada HC; Yucel-Lindberg T
Biochim Biophys Acta; 2007 Oct; 1773(10):1589-98. PubMed ID: 17707523
[TBL] [Abstract][Full Text] [Related]
12. Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model.
Claveau D; Sirinyan M; Guay J; Gordon R; Chan CC; Bureau Y; Riendeau D; Mancini JA
J Immunol; 2003 May; 170(9):4738-44. PubMed ID: 12707354
[TBL] [Abstract][Full Text] [Related]
13. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1.
Guay J; Bateman K; Gordon R; Mancini J; Riendeau D
J Biol Chem; 2004 Jun; 279(23):24866-72. PubMed ID: 15044444
[TBL] [Abstract][Full Text] [Related]
14. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
Koeberle A; Pollastro F; Northoff H; Werz O
Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
[TBL] [Abstract][Full Text] [Related]
15. Despite transcriptional and functional coordination, cyclooxygenase-2 and microsomal prostaglandin E synthase-1 largely reside in distinct lipid microdomains in WISH epithelial cells.
Ackerman WE; Robinson JM; Kniss DA
J Histochem Cytochem; 2005 Nov; 53(11):1391-401. PubMed ID: 15983118
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1.
Gosset M; Pigenet A; Salvat C; Berenbaum F; Jacques C
J Immunol; 2010 Nov; 185(10):6244-52. PubMed ID: 20943996
[TBL] [Abstract][Full Text] [Related]
17. Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition.
Frölich S; Olliges A; Kern N; Schreiber Y; Narumiya S; Nüsing RM
Am J Physiol Renal Physiol; 2012 Jul; 303(2):F209-19. PubMed ID: 22573380
[TBL] [Abstract][Full Text] [Related]
18. Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells.
Stichtenoth DO; Thorén S; Bian H; Peters-Golden M; Jakobsson PJ; Crofford LJ
J Immunol; 2001 Jul; 167(1):469-74. PubMed ID: 11418684
[TBL] [Abstract][Full Text] [Related]
19. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
Korotkova M; Jakobsson PJ
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells.
Kojima F; Naraba H; Sasaki Y; Okamoto R; Koshino T; Kawai S
J Rheumatol; 2002 Sep; 29(9):1836-42. PubMed ID: 12233875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
